Maccura Biotechnology Co Ltd Class A 300463
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥12.10
- Day Range
- ¥12.27–12.95
- 52-Week Range
- ¥9.90–17.38
- Bid/Ask
- ¥12.85 / ¥12.86
- Market Cap
- ¥7.88 Bil
- Volume/Avg
- 13.5 Mil / 6.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 22.82
- Price/Sales
- 2.82
- Dividend Yield (Trailing)
- 1.20%
- Dividend Yield (Forward)
- 1.20%
- Total Yield
- 1.20%
Company Profile
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Value
- Total Number of Employees
- 3,362
- Website
- https://www.maccura.com/
Comparables
Valuation
|
Metric
|
300463
|
688468
|
603658
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.82 | 18.73 | 19.87 |
Price/Book Value | 1.22 | 1.82 | 3.10 |
Price/Sales | 2.82 | 5.48 | 5.53 |
Price/Cash Flow | 10.82 | 12.83 | 13.96 |
Price/Earnings
300463
688468
603658
Financial Strength
|
Metric
|
300463
|
688468
|
603658
|
|---|---|---|---|
Quick Ratio | 2.27 | 4.71 | 0.99 |
Current Ratio | 3.34 | 5.48 | 2.71 |
Interest Coverage | 12.34 | 111.54 | 57.12 |
Quick Ratio
300463
688468
603658
Profitability
|
Metric
|
300463
|
688468
|
603658
|
|---|---|---|---|
Return on Assets (Normalized) | 4.09% | 7.46% | 11.37% |
Return on Equity (Normalized) | 5.28% | 9.59% | 15.28% |
Return on Invested Capital (Normalized) | 4.82% | 7.98% | 14.14% |
Return on Assets
300463
688468
603658
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Vnvxfrbgx | Nsp | $234.7 Bil | |||
| Danaher Corp
DHR
| Ccdqftgw | Dslxf | $198.9 Bil | |||
| IQVIA Holdings Inc
IQV
| Rxzylrm | Gsdds | $42.8 Bil | |||
| Agilent Technologies Inc
A
| Mhfcxyqmh | Gnjph | $42.5 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Szhvmgpyw | Nbc | $42.1 Bil | |||
| Mettler-Toledo International Inc
MTD
| Kznzpzffr | Xbxlr | $31.4 Bil | |||
| Icon PLC
ICLR
| Xylltshvw | Hbfml | $23.7 Bil | |||
| Waters Corp
WAT
| Gvqnhmjyf | Xjw | $21.2 Bil | |||
| Illumina Inc
ILMN
| Zrgwyghlw | Thpxwqy | $20.7 Bil | |||
| Labcorp Holdings Inc
LH
| Jqprzktsz | Bqsyms | $18.6 Bil |
United States